Level C· Early human research exploring benefitsCohort StudyPubMed

Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.

Dumesic DA., Tulberg A., Leung KL., Fisch SC., Grogan TR., Abbott DH.

Cohort Study on Type 2 Diabetes, published in Fertil Steril (2020) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
Fertil Steril (2020)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
33341231
PMCID
PMC8209112
DOI
10.1016/j.fertnstert.2020.10.003
Citations
22

Abstract (original English)

Objective To examine whether subcutaneous (SC) abdominal adipose stem cell differentiation into adipocytes in vitro predicts insulin sensitivity (Si) in vivo in normal-weight women with polycystic ovary syndrome (PCOS) and controls. Design Prospective cohort study. Setting Academic medical center. Patient(s) Eight normal-weight women with PCOS and 8 age- and body mass index-matched controls. Intervention(s) Women underwent circulating hormone/metabolic determinations, intravenous glucose tolerance testing, total-body dual-energy x-ray absorptiometry, and SC abdominal fat biopsy. Main outcome measure(s) PPARγ and CEBPa gene expression and lipid content of adipocytes matured in vitro were compared between women with PCOS and control women, and correlated with patient characteristics, systemic Si, and adipose insulin resistance (adipose-IR). Result(s) Serum androgen levels, adipose-IR, and percentage of android fat were greater in women with PCOS than control women. Stem cell PPARγ and CEBPa gene expression increased maximally by day 12 without a female-type effect. In control cells, gene expression positively correlated with fasting serum insulin levels (both genes) and adipose-IR (CEBPa) and negatively correlated with Si (CEBPa). Conversely, CEBPa gene expression in PCOS cells negatively correlated with adipose-IR and serum free testosterone, whereas total lipid accumulation in

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Abdominal FatAdipocytesAdipogenesisAdiposityAdultCCAAT-Enhancer-Binding ProteinsCase-Control StudiesCells, CulturedFemaleHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research